|
|
|
|
|
Product Name
|
GM130 antibody [NN 2C10/1] - Golgi Marker
|
| |
See all GM130 - Golgi Marker antibodies (6)...
|
|
Product type
|
Primary antibodies
|
|
Description
|
Mouse monoclonal [NN 2C10/1] to GM130 - Golgi Marker
|
|
Immunogen
|
Recombinant full length protein (Rat).
|
|
Reacts with
|
Rat
|
|
Does not react with
(species key)
|
Hu
|
|
Tested applications
(see key)
|
EM, ICC/IF, IHC-P, WB
|
|
|
Abreviews
|
|
|
|
Application notes
(see key)
|
Recommended dilutions EM: Use at an assay dependent dilution (PMID 19015319). ICC/IF: 1/200 (PMID 19022387). IHC-P: Use at an assay dependent concentration. WB: Use at an assay dependent concentration.
Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.
|
|
Cellular localization
|
Peripheral membrane protein associated with Golgi stacks
|
|
Research areas
|
Signal Transduction >> Protein Trafficking >> Golgi Proteins Tags & Cell Markers >> Subcellular Markers >> Organelles >> Golgi
|
|
Relevance
|
The Golgi apparatus, which participates in glycosylation and transport of proteins and lipids in the secretory pathway, consists of a series of stacked cisternae (flattened membrane sacs). Interactions between the Golgi and microtubules are thought to be important for the reorganization of the Golgi after it fragments during mitosis. GM130 encodes a member of the Golgin protein family and is localised to the Golgi. The protein encoded by GM130 has been postulated to play roles in the stacking of Golgi cisternae, maintaining cis-Golgi structure and in vesicular transport. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of these variants has not been determined. GM130 is part of a larger oligomeric complex which interacts with p115, GORASP1/GRASP65 and RAB1B that has been activated by GTP-binding. GM130 is useful as a cis-Golgi marker in immunohistochemistry.
|
|
|
|
|
Database links
|
The links below go to external sites and will open in a new browser window
|
|
Raised in
|
Mouse
|
|
Clonality
|
Monoclonal
|
|
Clone number
|
NN 2C10/1
|
|
Myeloma
|
Sp2
|
|
Isotype
|
IgG2a
|
|
Purity
|
Protein A purified
|
|
Storage buffer
|
Phosphate buffered saline
|
|
Form
|
Liquid
|
|
Concentration
|
0.750 mg/ml
|
|
Storage instructions
|
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
|
| |
At Abcam, we have one centralized database to hold all of our product information, so that everything we know about this GM130 antibody [NN 2C10/1] - Golgi Marker is on this datasheet. But please do contact us if you would like any reassurance! |
 |
|
References for GM130 antibody [NN 2C10/1] - Golgi Marker (ab1299)
|
|
This product has been used in: (two most recent references)
Merianda TT et al. A functional equivalent of endoplasmic reticulum and Golgi in axons for secretion of locally synthesized proteins. Mol Cell Neurosci 40:128-42 (2009). ICC/IF; Rat. PubMed: 19022387
Li Y et al. HUMMR, a hypoxia- and HIF-1alpha-inducible protein, alters mitochondrial distribution and transport. J Cell Biol 185:1065-81 (2009). ICC/IF; Mouse. PubMed: 19528298
See all 10 publication references for this product.
If you publish research using ab1299 please let us know so that we can cite the reference on this datasheet.
|
| |
|
Search PubMed (MEDLINE) for references to GM130
|
| |
GM130 antibody [NN 2C10/1] - Golgi Marker - more information
|
Customer reviews (feedback) regarding GM130 antibody [NN 2C10/1] - Golgi Marker |
Customer FAQs regarding GM130 antibody [NN 2C10/1] - Golgi Marker |
Protocols for GM130 antibody [NN 2C10/1] - Golgi Marker |
Price and availability of products related to GM130 antibody [NN 2C10/1] - Golgi Marker |
| |
GM130 antibody [NN 2C10/1] - Golgi Marker - related products:
|
|
|
| |
GM130 antibody [NN 2C10/1] - Golgi Marker - other tools:
|
Contact Abcam with a Technical Enquiry about GM130 antibody [NN 2C10/1] - Golgi Marker |
| |
All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"